Foley Mark J
CIK: 0001529196•President & CEO
OfficerDirector
Primary company: Zeltiq Aesthetics Inc (ZLTQ)
Foley Mark J is a corporate insider (President & CEO) at Zeltiq Aesthetics Inc (ZLTQ) filing SEC Form 4 transactions. 231 transactions across 4 companies, totaling $1,264,492 in purchases and $27,902,898 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
GLAUKOS Corp GKOS | Award | 2,987 | $106.52 | $318K | 2,987 | 5/28/2026 Filed: 5/28/2026 | Filing → |
GLAUKOS Corp GKOS | Award | 2,987 | $53.57 | $160K | 2,987 | 5/28/2026 Filed: 5/28/2026 | Filing → |
GLAUKOS Corp GKOS | Award | 1,878 | - | - | 60,267 | 5/28/2026 Filed: 5/28/2026 | Filing → |
GLAUKOS Corp GKOS | Award | 1,168 | - | - | 58,389 | 1/2/2026 Filed: 1/2/2026 | Filing → |
GLAUKOS Corp GKOS | Award | 3,149 | - | - | 3,149 | 5/29/2025 Filed: 6/2/2025 | Filing → |
GLAUKOS Corp GKOS | Award | 2,108 | - | - | 57,221 | 5/29/2025 Filed: 6/2/2025 | Filing → |
GLAUKOS Corp GKOS | Award | 864 | - | - | 35,800 | 1/2/2025 Filed: 6/2/2025 | Filing → |
GLAUKOS Corp GKOS | Exercise | 15,000 | $24.69 | $370K | 0 | 2/26/2025 Filed: 2/28/2025 | Filing → |
GLAUKOS Corp GKOS | Exercise | 25,000 | $32.00 | $800K | 0 | 2/26/2025 Filed: 2/28/2025 | Filing → |
GLAUKOS Corp GKOS | Sale | 20,687 | $120.72 | $2.50M | 54,249 | 2/26/2025 Filed: 2/28/2025 | Filing → |
GLAUKOS Corp GKOS | Exercise | 15,000 | $24.69 | $370K | 74,936 | 2/26/2025 Filed: 2/28/2025 | Filing → |
GLAUKOS Corp GKOS | Exercise | 25,000 | $32.00 | $800K | 59,936 | 2/26/2025 Filed: 2/28/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | Disposition | 84,686 | - | - | 0 | 2/6/2025 Filed: 2/6/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | Award | 84,686 | - | - | 84,686 | 2/6/2025 Filed: 2/6/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | Disposition | 27,933 | - | - | 0 | 2/6/2025 Filed: 2/6/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | U | 110,913 | $3.65 | $405K | 0 | 2/4/2025 Filed: 2/6/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | U | 996,935 | $3.65 | $3.64M | 27,933 | 2/4/2025 Filed: 2/6/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | Award | 27,933 | - | - | 1,024,868 | 2/3/2025 Filed: 2/5/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | Award | 1,000 | $2.18 | $2K | 996,935 | 12/31/2024 Filed: 1/3/2025 | Filing → |
Revance Therapeutics, Inc. RVNC | Award | 1,000 | $2.18 | $2K | 995,935 | 6/30/2024 Filed: 7/2/2024 | Filing → |
GLAUKOS Corp
GKOS
Type
Award
Shares
2,987
Price
$106.52
Value
$318K
GLAUKOS Corp
GKOS
Type
Award
Shares
2,987
Price
$53.57
Value
$160K
GLAUKOS Corp
GKOS
Type
Award
Shares
1,878
Price
-
Value
-
GLAUKOS Corp
GKOS
Type
Award
Shares
1,168
Price
-
Value
-
GLAUKOS Corp
GKOS
Type
Award
Shares
3,149
Price
-
Value
-
GLAUKOS Corp
GKOS
Type
Award
Shares
2,108
Price
-
Value
-
GLAUKOS Corp
GKOS
Type
Award
Shares
864
Price
-
Value
-
GLAUKOS Corp
GKOS
Type
Exercise
Shares
15,000
Price
$24.69
Value
$370K
GLAUKOS Corp
GKOS
Type
Exercise
Shares
25,000
Price
$32.00
Value
$800K
GLAUKOS Corp
GKOS
Type
Sale
Shares
20,687
Price
$120.72
Value
$2.50M
GLAUKOS Corp
GKOS
Type
Exercise
Shares
15,000
Price
$24.69
Value
$370K
GLAUKOS Corp
GKOS
Type
Exercise
Shares
25,000
Price
$32.00
Value
$800K
Revance Therapeutics, Inc.
RVNC
Type
Disposition
Shares
84,686
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
84,686
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
Disposition
Shares
27,933
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
U
Shares
110,913
Price
$3.65
Value
$405K
Revance Therapeutics, Inc.
RVNC
Type
U
Shares
996,935
Price
$3.65
Value
$3.64M
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
27,933
Price
-
Value
-
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
1,000
Price
$2.18
Value
$2K
Revance Therapeutics, Inc.
RVNC
Type
Award
Shares
1,000
Price
$2.18
Value
$2K
AI Agent
Try asking...